US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,860.76

-6.7429-0.36%

Number of Gainers:9

Number of Losers:10

Number of Flat:- -

PE:- -

High:1,867.96

Open:1,864.69

Low:1,848.51

Close:1,867.50

Volume:117.81M

Turnover:8.90B

Market Cap:1.51T

Float Cap:1.48T

Loading ...

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS

Sanofi Spokesperson Says Nuvaxovid to be Available Across U.S. for 2026-27 Respiratory Virus Season

NYSE Most Active Issues

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Pfizer, BioNTech Win FDA Approval for XFG-Adapted COVID-19 Vaccine in High-Risk US Adults

Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Immediately

THOMSON REUTERS

Pfizer - 2026-2027 Covid-19 Vaccine Formula Targets Xfg Variant Per FDA Guidance

THOMSON REUTERS

Moderna Wins FDA Approval for Updated 2026-2027 COVID-19 Vaccines Targeting JN.1-Lineage XFG Subvariant

Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike

THOMSON REUTERS

Moderna - Updated Formula for Spikevax is NOW Approved for Individuals 6 Months Through 64 Years of Age with at Least One Underlying Condition

THOMSON REUTERS

Moderna: Updated Covid-19 Vaccines Expected Available in Coming Days

THOMSON REUTERS

Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled

Sector Update: Healthcare

MT Newswires Live

AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BK4568/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1860.7577,"timestamp":1788206399999,"preClose":1867.5006,"halted":0,"volume":117813789,"delay":0,"changeRate":-0.003611,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-6.74292,"latestTime":"08-31 16:00:00 EDT","open":1864.6931,"high":1867.9595,"low":1848.5083,"amount":8899813897.293772,"amplitude":0.010416,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.8712,"peRate":47.437581,"turnoverRate":0.008494,"increases":9,"decrements":10,"flats":0,"marketCap":1514387387814,"floatMarketCap":1479260492648},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1867.9595,"amplitude":0.010416,"preClose":1867.5006,"low":1848.5083,"pbRate":"4.8712","latestPrice":1860.7577,"volume":117813789,"delay":0,"open":1864.6931,"prevYearClose":1637.1339,"prevWeekClose":1867.5006,"prevMonthClose":1741.4208,"prevQuarterClose":1731.2963,"fiveDayClose":1903.568,"twentyDayClose":1718.7439,"sixtyDayClose":1648.69,"secType":"PLATE","market":"US","turnoverRate":0.008494,"peRate":47.437581,"marketCap":1514387387814,"floatMarketCap":1479260492648,"timestamp":1788206399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":9,"down":10,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662394370","title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662394370","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662394370?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870729,"startTime":"0","endTime":"0","summary":"Gilead Sciences director Anthony Welters disposes of USD 2.64 million in common sharesGilead director Anthony Welters exercised stock options for 18,000 shares on Aug. 26, 2026 at prices of USD 60.67 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL29Bbzm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2324357040.USD","LU1674673428.USD","LU1023059063.AUD","SG9999015986.USD","LU0058720904.USD","IE00B19Z3581.USD","LU0122379950.USD","LU2087621335.USD","LU1585245621.USD","IBBQ","LU0861579265.USD","MEDI","IE00BSNM7G36.USD","LU1430594728.SGD","BK4585","BK4583","BK4588","LU1934455863.HKD","LU0289739699.SGD","LU1057294990.SGD","LU1066051498.USD","LU0889565916.HKD","LU1037948897.HKD","BK4578","LU0823416689.USD","BMED","IE00B7SZLL34.SGD","BK4568","BK4532","TBXU","LU1061106388.HKD","BBH","LU0965508806.USD","BK4139","IBB","LU0965509010.AUD","GILD","IE00B19Z3B42.SGD","LU0965509101.SGD","TMED","LU1839511570.USD","LU2112291526.USD","BIB","LU0109394709.USD","IE00B3T34201.USD","LU1571399168.USD","IE0002270589.USD","LU0859254822.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036059","title":"Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036059?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:55","pubTimestamp":1787867719,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced that the FDA approved Bixlenvo – bictegravir 75 mg/lenacapavir 50 mg -, the smallest once-daily single tablet regi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","LABU","LU0965509101.SGD","LU1674673428.USD","BK4532","LU0823416689.USD","IBB","LU1066053197.SGD","LU1934455194.USD","LU2357627491.SGD","BBH","BK4568","SG9999015986.USD","LU0861579265.USD","LU1066051498.USD","BK4588","LU0234570918.USD","LU0889565916.HKD","LU1037948897.HKD","BIB","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0859254822.USD","IE00B19Z3581.USD","BK4566","SG9999015952.SGD","TMED","LU0109394709.USD","LU1839511570.USD","IBBQ","GILD","LU0058720904.USD","LU1023059063.AUD","LU1061106388.HKD","MEDI","IE00B19Z3B42.SGD","LU1585245621.USD","BK4585","BMED","LU1674673691.USD","BK4583","LU2087621335.USD","SG9999015945.SGD","LU2324357040.USD","LU0965509283.SGD","TBXU","LU1571399168.USD","LU0122379950.USD","LU1934455863.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036807","title":"U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036807?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:47","pubTimestamp":1787867220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7M9KZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4585","SG9999015978.USD","LU2089984988.USD","MEDI","BBH","IE00B19Z3B42.SGD","LU0320765992.SGD","LU0965509283.SGD","IE00B7SZLL34.SGD","LU1571399168.USD","BK4550","BIB","LU2087621335.USD","LU0109394709.USD","LU2468319806.SGD","LU1066051498.USD","LU0234570918.USD","BK4532","TBXU","LU0823416689.USD","LU0861579265.USD","LU1934455194.USD","SG9999015945.SGD","IBBQ","BK4583","LU1066053197.SGD","BMED","LU0289739699.SGD","BK4566","TMED","LU0882574055.USD","GILD","IE00B3T34201.USD","LU1934455277.USD","LU0965509010.AUD","LU1057294990.SGD","IBB","BK4578","LU1839511570.USD","LU1061106388.HKD","LU1430594728.SGD","LU2112291526.USD","LU1037948897.HKD","LU1778281490.HKD","IE00BKVL7J92.USD","BK4588","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036864","title":"Sanofi Spokesperson Says Nuvaxovid to be Available Across U.S. for 2026-27 Respiratory Virus Season","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036864","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036864?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:43","pubTimestamp":1787867012,"startTime":"0","endTime":"0","summary":"BRIEF-Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus SeasonAug 28 (Reuters)-Sanofi Spokesperson:NUVAXOVID WILL BE AVAILABLE ACROSS U.S. FOR THE 2026-2027 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1JT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4588","NVAX","BK4568","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036856","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036856","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036856?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:40","pubTimestamp":1787866800,"startTime":"0","endTime":"0","summary":"BitMine Immersion Techs     BMNR    55,890,185     25.63     0.72      2.89. Nu Holdings Cl A              NU    47,688,503     14.88    -0.29     -1.91. Bank of America              BAC    44,490,310     61.17    -1.06     -1.70. Nike Cl B                    NKE    36,364,288     38.44    -0.15     -0.39","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4592","LU2265009873.SGD","LU1074936037.SGD","VFH","FTXO","LU0170899867.USD","LU0070302665.USD","IYF","BK4585","KBWB","LU1069347547.HKD","IYG","BK4504","BK4207","LU1496350171.SGD","BK4599","LU0787776722.HKD","BK4561","IE00BLSP4452.SGD","FNCL","IE00B3T34201.USD","LU0130102774.USD","IE00B19Z3581.USD","LU2129689605.HKD","IE0034235188.USD","BK4543","LU0320765646.SGD","XLF","PATH","IE00B19Z3B42.SGD","LU0683600562.USD","LU0320765489.SGD","TFNS","PFE","SG9999003800.SGD","PATX","LU0417517546.SGD","LU1989771016.USD","LU1057294990.SGD","BK4533","LU0053666078.USD","LU0477156953.USD","LU0234572021.USD","LU0321505868.SGD","LU0456855351.SGD","LU0234570918.USD","BAC","OZEM","UYG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035261","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035261?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:25","pubTimestamp":1787865900,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  shed 3.08% to $1.26 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.57% to 26,541.35 and the Dow Jones Industrial Average  rising 0.20% to 53,569.44.The stock's fall snapped a three-day winning streak.Inovio Pharmaceuticals Inc. closed 57.70% below its 52-week high of $2.98, which the company reached on September 9th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 1.57% to $265.77, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  fell 0.99% to $28.02.Trading volume  remained 1.4 million below its 50-day average volume of 3.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","BK4568","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603518","title":"Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603518","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662603518?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:19","pubTimestamp":1787865588,"startTime":"0","endTime":"0","summary":"Abbott CEO Robert B. Ford disposes of $ US 46.17 million in common sharesAbbott Laboratories Chairman and CEO Robert B. Ford reported option exercises, acquiring 398,832 common shares on Aug. 25, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8ZPBwh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU1914381329.SGD","LU1691799644.USD","BK4533","SG9999002224.SGD","LU0882574055.USD","LU0058720904.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU1989763427.SGD","BK4566","LU0114720955.EUR","LU0432979614.USD","LU0266013472.USD","LU0170899867.USD","SG9999004303.SGD","LU1721429741.USD","LU2468319806.SGD","BK4504","PJP","LU1061106388.HKD","SG9999002232.USD","LU0320765489.SGD","LU2237957902.USD","BK4592","BK4581","LU2237957811.SGD","LU0208291251.USD","LU2133065610.SGD","LU0211331839.USD","LU0289739699.SGD","IHI","BK4568","SGXZ41872573.SGD","IE00B2B36J28.USD","BK4082","ABT","LU1057294990.SGD","LU2112291526.USD","LU2211815571.USD","LU0868494617.USD","LU1721429402.USD","TMED","BK4585","LU0234572021.USD","LU0070302665.USD","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662035516","title":"FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662035516","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662035516?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:04","pubTimestamp":1787864640,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech.The agency gave a green light to supplemental biologics license applications for the 2026-2027 formulas to the Comirnaty vaccine, made by Pfizer and BioNTech, and Moderna's mNexspike and Spikevax shots. The new formulas are designed to target the XFG variant of Covid-19.Pfizer and BioNTech said the new formulation of its vaccine would begin shipping immediately for use beginning in the fall. Moderna said its updated vaccines will be available in the coming days.All three vaccines were approved for adults 65 years of age and older. The FDA also approved the shots for individuals younger than 65 whose underlying conditions put them at high risk for severe outcomes from Covid-19. Those approvals extend as young as 12 years old for mNexspike, five years for Comirnaty, and six months for Spikevax.\"Our updated COVID-19 vaccines help protect those at high risk of severe diseas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","IDNA","LU0306807586.USD","LU1023059063.AUD","IE00BBT3K403.USD","BK4533","IE00B3T34201.USD","SG9999013999.USD","LU0456855351.SGD","LU2596442595.SGD","SG9999002232.USD","BK4007","SG9999011175.SGD","BK4551","PFE","IE00BLSP4239.USD","LU0225771236.USD","LU0234572021.USD","LU1894683348.USD","LU1066053197.SGD","WDNA","SG9999001176.SGD","BK4534","BK4568","LU0225284248.USD","IE0002270589.USD","BK4599","IE00BLSP4452.SGD","LGHT","MRNX","LU0321505868.SGD","LU0321505439.SGD","SG9999002224.SGD","OZEM","SG9999001176.USD","LU1894683264.USD","BK4588","BNTX","MRNY","BK4585","LU0985481810.HKD","SGXZ57979304.SGD","BK4535","BK4592","LU1057294990.SGD","LU0289739699.SGD","BK4548","LU0170899867.USD","GNOM","LU0058720904.USD","BK4532","LU0306806265.USD","LU0122379950.USD","LU1883839398.USD","LU1066051498.USD","MRNA","SG9999003800.SGD","LU0868494617.USD","BK4139","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4581","BK4550","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033176","title":"Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033176","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033176?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:35","pubTimestamp":1787862915,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) and BioNTech (BNTX) announced that the FDA has approved the supplemental Biologics License Application for the companies’ 2026-2027 CO...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-and-biontech-receive-fda-approval-for-xfg-adapted-covid-19-vaccine-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-and-biontech-receive-fda-approval-for-xfg-adapted-covid-19-vaccine-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.USD","SG9999013999.USD","SGXZ57979304.SGD","BK4533","BK4007","IE00BLSP4452.SGD","LU0306807586.USD","IE00BLSP4239.USD","BK4548","BK4534","IE00B19Z3B42.SGD","LU2596442595.SGD","SG9999001176.SGD","LU1894683348.USD","BK4588","LU0225284248.USD","LU0122379950.USD","LU0985481810.HKD","LU0170899867.USD","LU0321505439.SGD","IE00BBT3K403.USD","BK4550","BNTX","IE000M9KFDE8.USD","LU0306806265.USD","LU1057294990.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU1883839398.USD","BK4599","LU0456855351.SGD","BK4535","LU1023059063.AUD","SG9999003800.SGD","LU0868494617.USD","OZEM","BK4139","SG9999002224.SGD","BK4568","LU1894683264.USD","PFE","LU0225771236.USD","SG9999011175.SGD","BK4581","BK4551","LU0289739699.SGD","LU0321505868.SGD","SG9999002232.USD","BK4585","IE00B3T34201.USD","BK4592","LU1066051498.USD","LU0234572021.USD","LU1066053197.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033626","title":"Moderna Inc. Stock Slips 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033626?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:34","pubTimestamp":1787862840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.6% to $142.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.6% to 26,541.35 and the Dow Jones Industrial Average rising 0.2% to 53,569.44.This was the stock's second consecutive day of losses.Moderna Inc. closed 19.2% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.6% to $265.77, Pfizer Inc. fell 1.0% to $28.02, and Gilead Sciences Inc. rose 0.52% to $148.86.Trading volume totaled 24.9 million, compared to the 50-day average of 16.4 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","WDNA","LU0058720904.USD","IE00B7SZLL34.SGD","BMED","LU1934455277.USD","MEDI","LGHT","LU0965509283.SGD","LU2357627491.SGD","MRNA","BK4139","IE00BKVL7J92.USD","BK4534","LU1934455194.USD","BK4533","SG9999015945.SGD","LU0861579265.USD","LU1674673691.USD","BIB","BK4588","LU1037948541.HKD","IDNA","IBBQ","BK4550","BK4568","BBH","TBXU","LU0114720955.EUR","LU2468319806.SGD","LU0965508806.USD","LU0109394709.USD","MRNX","BK4583","GILD","LU1061106388.HKD","LU0965509010.AUD","LU1674673428.USD","LU1066053197.SGD","BK4551","MRNY","LU0889565916.HKD","GNOM","TMED","IBB","LU2324357040.USD","LU0320765992.SGD","SG9999015952.SGD","SG9999015986.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203332","title":"Pfizer, BioNTech Win FDA Approval for XFG-Adapted COVID-19 Vaccine in High-Risk US Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203332","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203332?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:31","pubTimestamp":1787862691,"startTime":"0","endTime":"0","summary":"Pfizer, BioNTech win FDA approval for XFG-adapted COVID-19 vaccine in high-risk US adultsFDA cleared Pfizer’s supplemental filing for an XFG-adapted COMIRNATY COVID-19 shot for the 2026-2027 season.Au","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8F62z4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4534","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU1066051498.USD","BK4139","IE000M9KFDE8.USD","LU0234572021.USD","SG9999001176.USD","LU0225284248.USD","BK4585","LU0306807586.USD","LU1894683348.USD","OZEM","SG9999003800.SGD","LU0321505439.SGD","SG9999011175.SGD","IE00B3T34201.USD","PFE","SGXZ57979304.SGD","LU0985481810.HKD","LU1057294990.SGD","IE00B19Z3B42.SGD","BK4592","IE00B19Z3581.USD","BK4551","BK4007","BK4568","LU1883839398.USD","SG9999002224.SGD","LU0456855351.SGD","BK4599","IE0002270589.USD","SG9999002232.USD","LU2596442595.SGD","BK4581","BK4533","BK4548","LU0868494617.USD","BK4550","LU0122379950.USD","SG9999013999.USD","BK4588","LU1066053197.SGD","BNTX","IE00BBT3K403.USD","LU1894683264.USD","LU0289739699.SGD","LU0306806265.USD","LU0058720904.USD","LU1023059063.AUD","LU0225771236.USD","SG9999001176.SGD","LU0170899867.USD","LU0321505868.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662403380","title":"Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2662403380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662403380?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:30","pubTimestamp":1787862600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7VLGST:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0456855351.SGD","LU0225771236.USD","BK4592","LU1023059063.AUD","LU1883839398.USD","LU0985481810.HKD","LU1057294990.SGD","IE00B19Z3581.USD","SG9999002224.SGD","SG9999001176.USD","BK4581","BK4007","LU1894683264.USD","LU0321505439.SGD","BK4599","SG9999003800.SGD","IE00BLSP4452.SGD","LU1066051498.USD","IE00B3T34201.USD","BK4534","LU2596442595.SGD","SG9999001176.SGD","LU0225284248.USD","LU0868494617.USD","BK4568","LU0122379950.USD","LU0058720904.USD","SG9999011175.SGD","SGXZ57979304.SGD","BK4585","LU1894683348.USD","LU0321505868.SGD","BK4588","BK4533","IE0002270589.USD","IE00BBT3K403.USD","PFE","LU0306806265.USD","OZEM","BK4550","LU0306807586.USD","LU0289739699.SGD","SG9999013999.USD","SG9999002232.USD","LU1066053197.SGD","LU0170899867.USD","LU0234572021.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662382033","title":"Pfizer - 2026-2027 Covid-19 Vaccine Formula Targets Xfg Variant Per FDA Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2662382033","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662382033?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:30","pubTimestamp":1787862600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7VLGST:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","LU0058720904.USD","SG9999002232.USD","BK4585","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU2596442595.SGD","SG9999003800.SGD","LU0985481810.HKD","LU1894683264.USD","IE0002270589.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU1894683348.USD","BK4550","SG9999002224.SGD","LU0225771236.USD","BK4592","LU0321505868.SGD","LU0868494617.USD","LU1066051498.USD","BK4007","LU0122379950.USD","LU1023059063.AUD","LU1066053197.SGD","LU1883839398.USD","LU0289739699.SGD","LU0456855351.SGD","IE00B19Z3581.USD","IE00B3T34201.USD","PFE","SG9999001176.USD","SG9999013999.USD","OZEM","LU0170899867.USD","SG9999011175.SGD","LU0306806265.USD","LU1057294990.SGD","LU0225284248.USD","IE00BBT3K403.USD","LU0321505439.SGD","IE00BLSP4239.USD","BK4534","BK4599","LU0306807586.USD","BK4581","BK4588","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080060","title":"Moderna Wins FDA Approval for Updated 2026-2027 COVID-19 Vaccines Targeting JN.1-Lineage XFG Subvariant","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080060","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080060?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860727,"startTime":"0","endTime":"0","summary":"Moderna wins FDA approval for updated 2026-2027 COVID-19 vaccines targeting JN.1-lineage XFG subvariantFDA cleared Moderna’s updated 2026-2027 COVID-19 vaccine formulas targeting the JN.1-lineage XFG ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL395HN3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","WDNA","BK4532","BK4501","IDNA","MRNA","BK4588","BK4533","MRNY","BK4534","BK4568","BK4585","BK4139","MRNX","LGHT","BK4551","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662800610","title":"Moderna - FDA Approved Sbla for 2026-2027 Formulas for Spikevax and Mnexspike","url":"https://stock-news.laohu8.com/highlight/detail?id=2662800610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662800610?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","BK4568","BK4501","BK4588","MRNA","GNOM","BK4551","BK4548","BK4533","IDNA","BK4139","LGHT","MRNY","BK4585","BK4532","WDNA","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080096","title":"Moderna - Updated Formula for Spikevax is NOW Approved for Individuals 6 Months Through 64 Years of Age with at Least One Underlying Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080096?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","MRNX","BK4501","BK4568","MRNA","BK4139","BK4551","BK4585","IDNA","BK4548","WDNA","BK4532","BK4534","LGHT","GNOM","BK4588","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080095","title":"Moderna: Updated Covid-19 Vaccines Expected Available in Coming Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080095?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860725,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O15C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDNA","MRNA","BK4532","GNOM","BK4588","BK4534","BK4551","MRNY","BK4501","BK4139","BK4568","BK4585","MRNX","BK4548","LGHT","BK4533","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808054","title":"Moderna Inc Stock (MRNA) Moved Down by 5.69% on Aug 27: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808054","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808054?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:15","pubTimestamp":1787858128,"startTime":"0","endTime":"0","summary":"• Moderna announced a proposed two billion dollar convertible senior notes private placement.\n• The pullback followed profit-taking after positive Phase 3 clinical trial developments.\n• Annual revenue stands at $1.94 billion alongside a net profit of $-2.82 billion.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262136721-market-movers-mrna-20260827","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4568","BK4501","BK4548","BK4534","BK4551","MRNA","BK4139","BK4588","BK4585","GNOM","MRNX","WDNA","IDNA","MRNY","LGHT","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662017084","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662017084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662017084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:03","pubTimestamp":1787850204,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF  shedding 0.7%.The iShares Biotechnology ETF  was fractionally lower.In corporate news, Moderna  shares fell 5.6% after it said Thursday it plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4548","XBI","LU0029874061.USD","IBB","HCSG","BK4139","STT","BK4581","MRNX","BK4533","LU0128526141.USD","WDNA","MRNY","BK4585","BK4588","GNOM","BK4534","BK4501","BK4568","BK4137","LABU","IDNA","FDN","BK4551","XLV","LGHT","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084908","title":"AstraZeneca Targets Pediatric Asthma Gains With New Glycopyrronium Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084908","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084908?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848302,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) is running a Phase II trial called “A Phase II...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-targets-pediatric-asthma-gains-with-new-glycopyrronium-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-targets-pediatric-asthma-gains-with-new-glycopyrronium-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","BK4585","LU0029864427.USD","AZNH","IE00B3T34201.USD","LU2237443622.USD","LU0128525929.USD","LU2456880835.USD","LU0058720904.USD","AZN","LU2237443382.USD","LU2417539215.USD","LU0889565916.HKD","LU2237443978.SGD","LU0432979614.USD","LU1829250122.USD","LU2237443465.HKD","LU2089984988.USD","LU2462157665.USD","LU2237443549.SGD","BK4588","LU1267930573.SGD","LU0289739699.SGD","LU0109394709.USD","LU2236285917.USD","LU2237443895.HKD","BK4007","BK4568","LU0708994859.HKD","LU0310800379.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":4,"totalSize":390,"code":"91000000","status":"200"}]}}